Article

The burden of RSV-associated illness in children aged <5 years, South Africa, 2011 to 2016

2022-06-21

Abstract excerpt

<h4>Background</h4> Vaccines and monoclonal antibodies to protect the very young infant against respiratory syncytial virus (RSV)-associated illness are effective for limited time periods. We aimed to estimate age-specific burden to guide implementation strategies and cost effectiveness analyses. <h4>Methods</h4> We combined case-based surveillance and ecological data to generate a national estimate of the burden...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1ac4620a-169f-5daf-86cd-547760a16ed7
DOI: 10.1101/2022.06.20.22276680

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The burden of RSV-associated illness in children aged <5 years, South Africa, 2011 to 2016DOI 10.1101/2022.06.20.22276680Read

Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South AfricaSemantic proximity Read

Clinical and economic burden of Respiratory Syncytial Virus in children aged 0-5 years in ItalySemantic proximity Read

The landscape of paediatric infectious disease exposure in a rural sub-Saharan Africa setting in Kilifi, Kenya: longitudinal serological analysis over two decades and priorities for future vaccine developmentSemantic proximity Read

Factors associated with severe respiratory syncytial virus infection among hospitalized children in Thammasat University HospitalSemantic proximity Read

Burden of Disease of Respiratory Syncytial Virus in Older Adults and Adults Considered at High Risk of Severe InfectionSemantic proximity Read

Respiratory syncytial virus hospitalisations among young children: a data linkage studySemantic proximity Read

Modelling the transmission dynamics of RSV and the impact of routine vaccinationSemantic proximity Read

The nasopharyngeal microbiome in South African children with lower respiratory tract infection: a nested case-control study of the Drakenstein Child Health StudySemantic proximity Read

Clinical characterisation and phylogeny of respiratory syncytial virus infection in hospitalised children at Red Cross War Memorial Children's Hospital, Cape Town.Semantic proximity Read

Cost-effectiveness of respiratory syncytial virus vaccination for older adults: a modelling analysisSemantic proximity Read

Impact of respiratory syncytial virus in the United States.Semantic proximity Read

On the relative role of different age groups during epidemics associated with the respiratory syncytial virusSemantic proximity Read